FDA Inspection
Scinopharm Taiwan LtdScinopharm Taiwan Ltd – FDA Inspection, Mar 29, 2012
Record Details
This FDA Inspection record concerns Scinopharm Taiwan Ltd, with an inspection on March 29, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Scinopharm Taiwan Ltd
- Inspection Date
- March 29, 2012
- Product Type
- Drugs
View Company Profile
ID · ffdf6876-5ab7-4104-85ad-a0fd0f722d4f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 778186
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Scinopharm Taiwan Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 23, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| March 21, 2024 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 25, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 10, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Scinopharm Taiwan Ltd
- FDA Inspection 1326554 - 2026-06-23
- FDA Inspection 1235581 - 2024-03-21
- FDA Inspection 1191835 - 2022-10-25
- FDA Inspection 1094253 - 2019-05-17
- FDA Inspection 1004952 - 2017-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.